AACR 2020: Study finds no overall survival benefit, but improved quality of life with talazoparib in advanced BRCA-mutated breast cancer
Phase III EMBRACA trial survival benefit results may be affected by subsequent treatments New data…
Browsing: advanced BRCA-mutated breast cancer